Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark Norway Sweden
  • Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study of Meclofenamate Sodium and Temozolomide for Patients with Progressive MGMT-Methylated Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Safety and Effectiveness of a Dendritic Cell Vaccine and Temozolomide for Patients with Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery

    Recruiting

    1 1 1 1
    Austria Belgium Denmark France Germany Italy +3
  • Study on Perampanel Treatment Before Surgery for Patients with Progressive Glioblastoma

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of Debio 0123 and Temozolomide for Adults with Recurrent or Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Spain
  • A study of 5-aminolevulinic acid with radiotherapy (radiodynamic therapy) for patients with first recurrence of glioblastoma brain tumor

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study on Gemcitabine for Patients with Recurrent Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway